drugset / Trial / NCT07628972
Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if a vitamin-like substance called quercetin is safe for people who have a rare condition called Dyskeratosis congenita (DC) or telomere biology disorders (TBD).
Timeline
- Start
- 2026-05-29
- Primary completion
- 2028-09
- Completion
- 2028-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quercetin | Small molecule | 4000 mg | Oral |